Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New online therapy aims to clear Cancer-Related brain fog

NCT ID NCT07591857

First seen May 20, 2026 · Last updated Jun 22, 2026 · Updated 6 times

Summary

This study tests a remote group program called CRAFT-G for breast cancer survivors who struggle with memory, focus, and thinking after treatment. The program includes six online group sessions led by an occupational therapist, plus brain-training exercises done at home. Researchers want to see if it improves cognitive function, mood, and daily life, and whether it could be used in clinics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER SURVIVOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hadassah Medical Care

    RECRUITING

    Jerusalem, Israel

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CRAFT-G (Cognitive Retraining and Functional Treatment Group) - a remote group behavioral intervention with computerized cognitive training and psychoeducation

What this could lead to

If it works, this could offer a practical, home-based program to help breast cancer survivors manage memory and thinking problems.

What could go wrong

This is a small, early-stage trial with only 48 participants, so results may not apply to everyone. The intervention is behavioral, not a drug, so benefits may be modest.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.